Works matching IS 10837159 AND DT 2014 AND VI 19 AND IP 11

Results: 20

Clinical Trial Results. A Phase I/II Study of XELIRI Plus Bevacizumab as Second-Line Chemotherapy for Japanese PatientsWithMetastatic Colorectal Cancer (BIX Study)

Published in:

2014

By:

Yasuo Hamamoto;
Tatsuro Yamaguchi;
Tomohiro Nishina;
Kentaro Yamazaki;
Takashi Ura;
Takako Nakajima;
Ayumu Goto;
Ken Shimada;
Norisuke Nakayama;
Junichi Sakamoto;
Satoshi Morita;
Yasuhide Yamada

Publication type:

Journal Article

In Reply.

Published in:

2014

By:

Heijden, Lizz;
Dijkstra, P.D. Sander;
Sande, Michiel A.J.;
Kroep, Judith R.;
Nout, Remi A.;
Rijswijk, Carla S.P.;
Bovée, Judith V.M.G.;
Hogendoorn, Pancras C.W.;
Gelderblom, Hans

Publication type:

Letter to the Editor

Symptom Management and Supportive Care. A Prospective Study of Shortened Vitamin Supplementation Prior to Cisplatin-Pemetrexed Therapy for Non-Small Cell Lung Cancer.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1193, doi. 10.1634/theoncologist.2014-0221

By:

Takagi, Yusuke;
Hosomi, Yukio;
Sunami, Kuniko;
Nakahara, Yoshiro;
Okuma, Yusuke;
Yomota, Makiko;
Shimokawa, Tsuneo;
Nagamata, Makoto;
Iguchi, Mari;
Okamoto, Hiroaki;
Okamura, Tatsuru;
Shibuya, Masahiko

Publication type:

Article

Updated Product Label Allows Home Administration of Omacetaxine Mepesuccinate.

Published in:

2014

By:

Shen, Ann Q.;
Munteanu, Mihaela;
Khoury, Hanna Jean

Publication type:

Letter to the Editor

Gene Status in HER2 Equivocal Breast Carcinomas: Impact of Distinct Recommendations and Contribution of a Polymerase Chain Reaction-BasedMethod.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1117, doi. 10.1634/theoncologist.2014-0195

By:

Sapino, Anna;
Maletta, Francesca;
Verdun di Cantogno, Ludovica;
Macrì, Luigia;
Botta, Cristina;
Gugliotta, Patrizia;
Scalzo, Maria Stella;
Annaratone, Laura;
Balmativola, Davide;
Pietribiasi, Francesca;
Bernardi, Paolo;
Arisio, Riccardo;
Viberti, Laura;
Guzzetti, Stefano;
Orlassino, Renzo;
Ercolani, Cristiana;
Mottolese, Marcella;
Viale, Giuseppe;
Marchiò, Caterina

Publication type:

Article

Symptom Management and Supportive Care. The Opioid Rotation Ratio of Hydrocodone to Strong Opioids in Cancer Patients.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1185, doi. 10.1634/theoncologist.2014-0130

By:

Reddy, Akhila;
Yennurajalingam, Sriram;
Desai, Hem;
Reddy, Suresh;
Cruz, Maxine;
Wu, Jimin;
Liu, Diane;
Rodriguez, Eden Mae;
Waletich, Jessica;
Shin, Seong Hoon;
Gayle, Vicki;
Patel, Pritul;
Dalal, Shalini;
Vidal, Marieberta;
Tanco, Kimberson;
Arthur, Joseph;
Tallie, Kimmie;
Williams, Janet;
Silvestre, Julio;
Bruera, Eduardo

Publication type:

Article

Efficacy and Safety of the FOLFOX4 Regimen Versus Doxorubicin in Chinese Patients With Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the EACH Study.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1168, doi. 10.1634/theoncologist.2014-0190

By:

Qin, Shukui;
Cheng, Ying;
Liang, Jun;
Shen, Lin;
Bai, Yuxian;
Li, Jianfeng;
Fan, Jia;
Liang, Lijian;
Zhang, Yaqi;
Wu, Gang;
Rau, Kun‐Ming;
Yang, Tsai‐Shen;
Jian, Zhixiang;
Liang, Houjie;
Sun, Yan

Publication type:

Article

Endocrinology. MicroRNA Expression Profiles in the Management of Papillary Thyroid Cancer.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1140, doi. 10.1634/theoncologist.2014-0135

By:

Lee, James C.;
Gundara, Justin S.;
Glover, Anthony;
Serpell, Jonathan;
Sidhu, Stan B.

Publication type:

Article

Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1155, doi. 10.1634/theoncologist.2014-0032

By:

Kirstein, Martha M.;
Lange, Ansgar;
Prenzler, Anne;
Manns, Michael P.;
Kubicka, Stefan;
Vogel, Arndt

Publication type:

Article

Clinical Trial Results. A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1128, doi. 10.1634/theoncologist.2014-0305

By:

Kim, Tae Min;
Kim, Dong‐Wan;
Kang, Yoon‐Koo;
Chung, Jooseop;
Song, Hong‐Suk;
Kim, Hyo Jung;
Kim, Byung Soo;
Lee, Jong‐Seok;
Kim, Hawk;
Yang, Sung Hyun;
Yuh, Young Jin;
Bae, Sung Hwa;
Hyun, Myung Soo;
Jeon, Yoon Kyung;
Kim, Chul Woo;
Heo, Dae Seog

Publication type:

Article

Patient Experience and Attitudes Toward Addressing the Cost of Breast Cancer Care.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1134, doi. 10.1634/theoncologist.2014-0117

By:

Irwin, Blair;
Kimmick, Gretchen;
Altomare, Ivy;
Marcom, P. Kelly;
Houck, Kevin;
Zafar, S. Yousuf;
Peppercorn, Jeffrey

Publication type:

Article

Endocrinology. Novel Approaches in Anaplastic Thyroid Cancer Therapy.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1147, doi. 10.1634/theoncologist.2014-0182

By:

Hsu, Kun‐Tai;
Yu, Xiao‐Min;
Audhya, Anjon W.;
Jaume, Juan C.;
Lloyd, Ricardo V.;
Miyamoto, Shigeki;
Prolla, Tomas A.;
Chen, Herbert

Publication type:

Article

Clinical Trial Results. A Phase I/II Study of XELIRI Plus Bevacizumab as Second-Line Chemotherapy for Japanese PatientsWithMetastatic Colorectal Cancer (BIX Study).

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1130, doi. 10.1634/theoncologist.2014-0159

By:

Hamamoto, Yasuo;
Yamaguchi, Tatsuro;
Nishina, Tomohiro;
Yamazaki, Kentaro;
Ura, Takashi;
Nakajima, Takako;
Goto, Ayumu;
Shimada, Ken;
Nakayama, Norisuke;
Sakamoto, Junichi;
Morita, Satoshi;
Yamada, Yasuhide

Publication type:

Article

Clinical Trial Results. S-1 as Monotherapy or in Combination With Leucovorin as Second-Line Treatment in Gemcitabine-Refractory Advanced Pancreatic Cancer: A Randomized, Open-Label, Multicenter, Phase II Study.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1132, doi. 10.1634/theoncologist.2014-0223

By:

Ge, Feijiao;
Xu, Nong;
Bai, Yuxian;
Ba, Yi;
Zhang, Yanqiao;
Li, Fei;
Xu, Huayan;
Jia, Ru;
Wang, Yan;
Lin, Li;
Xu, Jianming

Publication type:

Article

Symptom Management and Supportive Care. Sleep-Related Breathing Disorders in Patients With Tumors in the Head and Neck Region.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1199, doi. 10.1634/theoncologist.2014-0176

By:

Faiz, Saadia A.;
Balachandran, Diwakar;
Hessel, Amy C.;
Lei, Xiudong;
Beadle, Beth M.;
William, William N.;
Bashoura, Lara

Publication type:

Article

Drug Development for Hepatocellular Carcinoma: Knowing the Past Helps to Understand the Future.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1114, doi. 10.1634/theoncologist.2014-0304

By:

Chan, Stephen L.

Publication type:

Article

Defining a New Role for the National Cancer Institute Cooperative Groups:More Science, Fewer Trials.

Published in:

2014

By:

Chabner, Bruce A.

Publication type:

Editorial

Giant Cell Tumor of Bone.

Published in:

2014

By:

Cavanna, Luigi;
Biasini, Claudia;
Monfredo, Michela;
Maniscalco, Pietro;
Mori, Monica

Publication type:

Image

Expanding Public-Private Collaborations to Enhance Cancer Drug Development:A Report of the Institute of Medicine’s Workshop Series, “Implementing a National Cancer Clinical Trials System for the 21st Century”.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1178, doi. 10.1634/theoncologist.2014-0240

By:

Bertagnolli, Monica M.;
Canetta, Renzo;
Nass, Sharyl J.

Publication type:

Article

Clinical Trial Results. A Pilot Study of Estradiol Followed by Exemestane for Reversing Endocrine Resistance in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1126, doi. 10.1634/theoncologist.2014-0306

By:

Chalasani, Pavani;
Stopeck, Alison;
Clarke, Kathryn;
Livingston, Robert

Publication type:

Article